FDA clears Dexcom real-time APIs for third-party apps and devices
Clearance Expands Connectivity and Interoperability of Dexcom CGM Digital Ecosystem
Allows guest third-party developers to connect applications and devices to CGM data in real time
Gives Dexcom users more choices about where and how they interact with their blood glucose data
SAN DIEGO, July 15, 2021– (BUSINESS WIRE) – DexCom, Inc. (NASDAQ: DXCM), the world leader in real-time continuous blood glucose monitoring for people with diabetes, today announced the approval of the Food and US Drug Administration (FDA) for Dexcom Partner Web APIs, enabling guest third-party developers to integrate real-time CGM data into their digital health applications and devices.
“FDA clearance of our real-time APIs further strengthens Dexcom as a leader in interoperable CGM, giving Dexcom users even more choice in how they view and interact with their glucose data,” said Jake Leach, CTO at Dexcom. “The new APIs will help seamlessly integrate the power of Dexcom CGM real-time data into some of the leading diabetes and digital health solutions. “
Several leading diabetes and digital health companies have been invited to access real-time APIs and are already in testing and development, including Garmin.® and Livongo from Teladoc Health® for diabetes.
“Garmin is excited about the opportunity to bring Dexcom CGM data to runners, cyclists and everyday users who rely on 24/7 technology to proactively manage their diabetes,” said Joe Schrick, vice-president. president of fitness at Garmin. “We are proud to be part of this integration which will allow users to quickly and discreetly view estimated glucose levels and trends directly from their smartwatch at any time.”
People with diabetes and their care providers will benefit from integrating real-time Dexcom CGM data into third-party applications and devices in multiple ways. For example, it:
Allow users to quickly see all of their therapy data in one place
Empower users to use the apps they find most useful for a more personalized Dexcom experience
Enable on-the-spot diabetes management coaching and feedback
For more information on Dexcom Real-Time APIs and other offerings for third-party developers, visit Dexcom.com/WebAPI.
About DexCom, Inc.
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Based in San Diego, California, Dexcom has established itself as a leader in diabetes care technology. By listening to the needs of users, caregivers and providers, Dexcom simplifies and improves the management of diabetes worldwide. For more information on Dexcom CGM, visit www.dexcom.com.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20210715006049/en/
James McIntosh, (619) 884-2118
Dexcom Public Relations
Sean Christensen, (858) 203-6657
Dexcom Corporate Affairs